The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7

European Journal of Immunology
K WillimannB Moser

Abstract

Secondary lymphoid-tissue chemokine, SLC, also known as exodus-2 and 6Ckine, is a novel CC chemokine with selectivity for T lymphocytes and preferential expression in lymphoid tissues. We have studied its production, receptor usage and biological activities. High levels of SLC mRNA were detected in lymph nodes, the gastrointestinal tract and several gland tissues, but no expression was found by Northern blot analysis in freshly isolated or stimulated blood monocytes and lymphocytes, or neutrophils and eosinophils. In situ hybridization revealed constitutive expression of SLC in the T cell areas and the marginal zone of follicles in lymph nodes and the mucosa-associated lymphoid tissue, but not in B cell areas or sinuses. Comparison with immunocytochemical staining showed similarity between the in situ expression of SLC and the distribution of interdigitating dendritic cells but not with sinus-lining dendritic cells, macrophages or T lymphocytes. SLC induced chemotaxis of T lymphocytes and its activity increased considerably when the cells were conditioned with IL-2 or phytohemagglutinin (PHA). Under optimal conditions SLC had unusually high efficacy and induced the migration of up to 50 % of input T lymphocytes. SLC also induce...Continue Reading

References

May 1, 1988·The Journal of Experimental Medicine·P PeveriM Baggiolini
Oct 13, 1995·Biochemical and Biophysical Research Communications·R BurgstahlerM Lipp
Oct 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P LoetscherB Moser
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·M W CarrT A Springer
Apr 1, 1996·European Journal of Immunology·D F LeglerB Moser
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·D Unutmaz, D R Littman
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·C C BleulC R Mackay
Sep 1, 1996·The Journal of Experimental Medicine·C C BleulT A Springer
Jan 1, 1997·Annual Review of Immunology·M BaggioliniB Moser
Jun 6, 1997·The Journal of Biological Chemistry·M BabaO Yoshie
Jul 11, 1997·The Journal of Biological Chemistry·R S RoosB Moser

❮ Previous
Next ❯

Citations

Jun 8, 1999·European Journal of Immunology·F SallustoA Lanzavecchia
Dec 18, 2001·European Journal of Immunology·G BardiP Loetscher
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Ewerton M MaggioSibrand Poppema
Feb 10, 2000·Springer Seminars in Immunopathology·U SyrbeA Hamann
Jan 13, 2001·Springer Seminars in Immunopathology·C CauxA Vicari
Jun 14, 2006·Cancer Metastasis Reviews·Dave S B HoonKlaus Pantel
Oct 1, 2013·Molecular Biology Reports·Rilun LiChunmin Liang
Dec 19, 2003·Current Allergy and Asthma Reports·Simon P HoganPaul S Foster
May 7, 2009·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Nazita YousefiehRichard P Ciavarra
Jun 21, 2005·Cytokine & Growth Factor Reviews·Silvano Sozzani
Nov 30, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·E VoulgarisN Pavlidis
May 14, 1999·Current Opinion in Immunology·M G McHeyzer-Williams, R Ahmed
Mar 26, 2003·Microbes and Infection·Wendy Peters, Joel D Ernst
Dec 27, 2012·ACS Nano·Leonard H Rome, Valerie A Kickhoefer
Aug 26, 2006·Nature Reviews. Immunology·Alistair J CochranRichard Essner
May 3, 2012·Nature Reviews. Rheumatology·Joseph E Craft
Feb 9, 2013·Integrative Biology : Quantitative Biosciences From Nano to Macro·Yana Wang, Darrell J Irvine
Jun 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·David A ZidarRobert J Lefkowitz
Apr 20, 1999·The Journal of Experimental Medicine·G DuludeC Perreault
Oct 19, 1999·The Journal of Experimental Medicine·G VassilevaS A Lira
Dec 6, 2000·The Journal of Experimental Medicine·P SchaerliB Moser
Aug 20, 2003·The Journal of Experimental Medicine·Alfonso MartIn-FontechaFederica Sallusto
Oct 6, 2005·The Journal of Experimental Medicine·Robbie B MailliardPawel Kalinski
Mar 13, 2008·International Immunology·Tilo Beyer, Michael Meyer-Hermann
Jan 26, 2002·Transplantation·Christophe CauxAlain Vicari
Jan 10, 2001·Inflammatory Bowel Diseases·K A Papadakis, S R Targan
Oct 12, 2005·Current Opinion in Hematology·Robert Sackstein
Oct 5, 2001·Clinical Microbiology Reviews·S W Chensue
Jun 3, 2000·Annual Review of Immunology·D Rossi, A Zlotnik
Nov 24, 1999·The Journal of Clinical Investigation·L MazzucchelliM Uguccioni
Apr 28, 2004·BMC Immunology·Yanina EberhardHoracio Marcelo Serra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.